This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Agricola R, Mazzarino M, Urani R (1982) Treatment of acute alcohol withdrawal syndrome with carbamazepine: A double blind comparison with triapride. J Intern Med Res 10: 160
Alldredge BK, Lowenstein PH, Simon RP (1989) Placebo-controlled trial of intravenous diphenylhydantoin for short-term treatment of alcohol withdrawal seizures. Am J Med 87: 645–648
Altamura AC, Mauri MC, Girardi T, Panetta B (1990) Alcoholism and Depression: A Placebo Controlled Study with Viloxazine. Int J Clin Pharmacol Res X(5): 293–298
Alverdes T, Bär E (1994) Ambulante Rehabilitation auf dem Prüfstand. In: Deutsche Hauptstelle gegen die Suchtgefahr (Hrsg) Jahrbuch Sucht 1995. Gestacht: Neulandverlag 1994. 194–209
American Psychiatric Association (1987) Diagnostic and statistical manual of mental disorders. 3rd edition, Revised. Washington DC, American Psychiatric Association
American Psychiatric Association APA (1994) Diagnostic and Statistical Manual of Mental Disorders, 4th edn. American Psychiatric Association, Washington. Deutsche Bearbeitung und Einführung von H. Saß, H.U. Wittchen und M. Zaudig. Hogrefe, Göttingen (1996)
Anderson P (1989) Self-Administered Questionnaires for Diagnosis of Alcohol Abuse. In: Watson RR (ed) Diagnosis of alcohol abuse. CRC Press, Boca Raton
Anton RF, Moak DH, Latham PK (1996) The obsessive compulsive drinking scale. Arch Gen Psychiatry 53: 217–226
Arolt V, Driessen M, Bangert-Verleger A, Neubauer H, Schürmann A, Seibert W (1995) Psychische Störungen bei internistischen und chirurgischen Krankenhauspatienten. Prävalenz und Behandlungsbedarf. Nervenarzt 66: 670–677
Ashley MJ, Olin JS, Le Riche WH, Kornaczewski A, Schimdt W, Rankin JW (1997) Morbidity in alcoholics: evidence for accelerated development of physical disease in women. Arch Intern Med 137: 883–887
Aulhorn E (1989) Die Tabak-Alkohol-Amblyopie. In: Schied HW, Heimann H, Mayer K (Hrsg): Der chronische Alkhoholismus. Grundlagen, Diagnostik, Therapie. Gustav Fischer, Stuttgart New York, S 163–174
Babor TF, Grant M (1989) From clinical research to secondary prevention international collaboration in the development of the Alcohol Use Disorders Indentification Test (AUDIT). Alcohol Health Res World 13: 371–374
Babor TF, Hofmann M, DelBoca FK, Hesselbrock V, Meyer R, Dolinsky ZS, Rounsaville B (1992) Types of alcoholics, I. Evidence for an empirically derived typology based on indicators of vulnerability and severity. Arch Gen Psychiatry 49: 599–608
Balldin J, Berggren U, Engel J, Eriksson M (1994) Neuroendocrine evidence for reduced serotonergic neurotransmission during heavy drinking. Alcohol Clin Exp Res 18: 822–825
Balldin J, Berglund M, Borg S, Mansson M, Berndtsen P, Franck J, Gustafsson L, Halldin J, Hollstedt C, Nilsson L-H, Stolt G (1997): A randomised 6 month doubleblind placebo-controlled study of naltrexone and coping skills educational programme, Alcohol Alcohol, X, SY 66
Ballenger JC, Post RM (1978) Kindling as a model for alcoholic withdrawal syndromes. Br J Psychiatry 133: 1–14
Baloh RW, Sharma S, Moskowitz H, Griffith R (1979): Effect of alcohol and marijuana on eye movements. Aviat Space Environ Med 50: 18–23
Banger M, Benkert O, Röschke J, Herth T, Hebenstreit M, Phillip M, Aldenhoff JB (1992) Nimodipine in acute alcohol withdrawal state. J Psychiatr Res 26: 117–123
Bansky G, Meier P, Riederer E et al. (1989) Effects of the benzodiazepine receptor antagonist flumazenil in hepatic encephalopathy in humans. Gastroenterology 97: 744–50
Baron R, Heuser K, Moarioth G (1989) Marchiafava-Bignami disease with recovery diagnosed by CT and MRI: demyelination affects several CNS structures. J Neurol 236: 364–366
Bartolomei F, Suchet L, Barrie M, Gastaut J-L (1997) Alcoholic Epilepsy: A Unified and Dynamic Classification. Eur Neurol 37: 13–17
Bässler KH, Gally I, Loew D, Pietczick (1997) Vitamin-Lexikon, 2. Auflage. Stuttgart Gustav Fischer
Benedetti G (1952) Die Alkoholhalluzinose. Stuttgart, Thieme
Beninger RJ, Ranaldi R (1993) Microinjections of flupenthixol into the caudateputamen but not the nucleus accumbens, amygdala or frontal cortex of rats produce intra-session declines in food-rewarded operant responding. Behav Brain Res 55: 203–212
Benkert O, Hippius H (1996) Psychiatrische Pharmakotherapie, 6. Auflage. Berlin Heidelberg New York: Springer
Bericht über die Lage der Psychiatrie in der BRD - Zur psychiatrischen und psychotherapeutischen/psychosomatischen Versorgung der Bevölkerung - Unterrichtung durch die Bundesregierung. Bonn: Bonner Universitätsbuchdruckerei (Drucksache 7/4201). 1975
Berlin I, Said S, Spreux-Varoquanx O, Launay J-M, Olivares R, Millet V, Lecrubier Y, Puech AJ (1995) A reversible monoamine oxidase A inhibitor (moclobemide) facilitates smoking cessation and abstinence in heavy, dependent smokers. Clin Pharmacol Ther 58: 444–452
Berr F, Wiebecke B (1994) Die akute Alkoholhepatitis. Dt Ärzteblatt 91: B2107–2110
Besson J, Aeby F, Kasas A, Lehert P, Potgieter A (1998) Combined Efficacy of Acamprosate and Disulfiram in the Treatment of Alcoholism: A Controlled Study. Alcohol Clin Exp Res 22: 573–579
Beutel M, Reeck UH (1995) Rehabilitation von Alkoholabhängigen. In: Seitz HK, Lieber CS, Simanowski UA (Hrsg): Handbuch Alkohol Alkoholismus Alkoholbedingte Organschäden. Leipzig Heidelberg: Johann Ambosius Barth: 591–606
Beyer H (1996) Stationäre Rehabilitation. In: Deutsche Hauptstelle gegen die Suchtgefahren (Hrsg) Jahrbuch Sucht. Gesthacht: Neulandverlag, 162–168
Blum K (1983) Alcohol and central nervous peptides substances. Subst Alcohol Actions/Misuse 4: 73–87
Blum K, Topel H (1986) Opioid peptides and alcoholism: genetic deficiency and chemical management. Functional Neurology 1: 71–83
BMJFFG (Hrsg) (1988) Empfehlungen der Expertenkommission der Bundesregierung zur Reform im psychiatrischen und psychotherapeutisch/psychosomatischen Bereich. Bonn
Bode JC (1995) Klinik und Therapie alkoholischer Leberschäden. In: Seitz HK, Lieber CS, Simanowski UA (Hrsg): Handbuch Alkohol Alkoholismus Alkoholbedingte Organschäden. Leipzig Heidelberg: Johann Ambrosius Barth: 237–259
Bode JC, Bode C (1992) Alcohol malnutrition and the gastrointestinal tract. In: Watson RR, Watzl B (eds): Nutrition and alcohol. Boca Raton: CRC Press: 403–428
Bohn MJ, Hersh D (1994) Drugs for the Treatment of Psychiatric Comorbidity in Alcoholics: Recent Developments. In: Born GVR, Cuatrecasas P, Ganten D, Herken H, Melmon KI (eds): The Pharmacology of Alcohol Abuse. Handbook of Experimental -/Pharmacology Vol. 114. Berlin Heidelberg New York: Springer: 416–441
Bohn MJ, Kranzler HR, Beazoglou D, Staehler BA (1994) Naltrexone and brief counseling to reduce heavy drinking. Am J Addict 3: 91–99
Bone GHA, Majchrowicz E, Martin PR et al. (1989) A Comparison of calcium antagonists and diazepam in reducing alcohol withdrawal tremors. Psycho-pharmacology 99: 386–388
Böning J (1996) Supportive medikamentöse Rückfallprophylaxe bei der Alkoholabhängigkeit. Nervenheilkunde 15: 72–79
Borg S, Kvande H, Valverius P (1986) Clinical conditions and central dopamine metabolism in alcoholics during acute withdrawal under treatment with different pharmacological agents. Psychopharmacology 88: 12–17
Borg V (1983) Bromocriptine in the prevention of alcohol abuse. Acta Psychiatr Scand 68: 100–110
Borgers D et al. (1990) Landesgesundheitsbericht NRW. Kapitel: Alkoholmißbrauch, Abschnitt 5.4 (unveröffentlicht)
Brady KT, Sonne SC, Anton R, Ballenger JC (1995) Valproate in the Treatment of Acute Bipolar Affective Episodes Complicated by Substance Abuse: A Pilot Study. J Clin Psychiatry 56: 118–121
Branchey L, Branchey M, Worner TM, Zucker D, Shaw S, Lieber CS (1985) Association between Amino Acid Alterations and Hallucinations in Alcoholic Patients. Biol Psychiatry 20: 1167–1173
Bratzke H, Neumann K (1989) Zentrale pontine Myelinolyse. Morphologie und forensische Relevanz. Z Rechtsmed 102: 79–97
Brecht JG, Poldrugo F, Schädlich PK (1996) Alcoholism - The cost of illness in the Federal Republic of Germany. Pharmaco Economics 10: 484–493
Bronisch T, Wittchen H-U (1992) Lifetime and 6-month prevalence of abuse and dependence of alcohol in the Munich Follow-Up Study. Eur Arch Psychiatry Clin Neurosci 241: 273–282
Bronisch Th (1985) Zur Beziehung von Alkoholismus und Depression anhand eines Überblickes über empirische Studien. Fortschr Neurol Psychiat 53: 454–468
Brown SA, Inaba RK, Gillin C, Schuckit M, Stewart MA, Irwin MR (1995): Alcoholism and Affective Disorder: Clinical Course of Depressive Symptoms. Am J Psychiatry 152: 45–52
Bruno F (1989) Buspirone in the Treatment of Alcoholic Patients. Psychopathology 22 (Suppl 1): 49–59
Bunse J, Zeit T (1987) Distraneurin und die Behandlung des Delirium tremens. Psycho 13: 670–675
Burkhardt E (1989) Intoxikation mit Carbamazepin bei bestehender Alkoholabhängigkeit in suizidaler Absicht - Eine Kasuistik. In: Müller-Oerlinghausen B, Haas S, Stoll K-D (Hrsg) Carbamazepin in der Psychiatrie. Thieme, Stuttgart New York, S 79–80
Castaigne P, Buge A, Cambier J, Escourolle R, Rancurel G (1971) La maladie de Marchiafava-Bignami: etude anatomoclinique de dix observations. Rev Neurol 125: 179–196
Chatterji et al. (1997) Reliability of the alcohol and drug modules of the Alcohol Use Disorder and Associated Disabilities Interview Schedule - Alcohol/Drug-Revised (AUDADIS-ADR): an international comparison. Drug and Alcohol Depend 47: 171–185
Chick J, Gough K, Falkowski W, Kershaw P, Hore B, Mehta B, Ritson B, Ropner R, Torley D (1992) Disulfiram treatment of alcoholism. Br J Psychiatry 161: 84–89
Ciraulo DA, Alderson LM, Chapron DJ, Jaffe JH, Subbarao B, Kramer PA (1982) Imipramine disposition in alcoholics. J Clin Psychopharmacol 2: 2–7
Ciraulo DA, Barnhill J, Boxenbaum H (1985) Pharmakokinetic interaction of disulfiram and antidepressants. Am J Psychiatry 142: 1373–1374
Clade H (1997) Rehabilitation: Lohnende Investition. Deutsches Ärzteblatt 94: B-1940
Cloninger CR, Bohman M, Sigvardsson S (1981) Inheritance of alcohol abuse - cross fostering analysis of adopted men. Arch Gen Psychiatry 42: 1043–1049
Cloninger CR, Przybeck TR, Svarkic DM (1991) The tridimensinonal personality questionnaire: US. Normative data. Psychol Rep, 69: 1047–1057
Conde-Martel A, Gonzalez-Reimers E, Santolaria-Fernandez F, Romero-Perez JC, Gonzalez-Hernandez T (1992) Pathogenesis of alcoholic myopathy: roles of ethanol and malnutrition. Drug Alcohol Depend 30: 101–110
Cook BL, Winokur G (1985) Separate heretability of alcoholism and psychotic symtoms. Am J Psychiatry 142: 360–361
Cornelius J, Salloum IM, Cornelius MD, Perel JM, Thase ME, Ehler JG, Mann JJ (1993) Fluoxetine trial in suicidal depressed alcoholics. Psychopharm Bull 29: 195–199
Cornelius J, Salloum IM, Ehler JG, Darrett PJ, Cornelius MD, Perel JU, Thase ME Black A (1997) Fluoxetine in depressed alcoholics. Arch Gen psychiatry 54: 700–705
Cornelius JR, Fisher BW, Salloum IM, Cornelius MD, Ehler JG (1992) Fluoxetine trial in depressed alcoholics. Alcohol Clin Exp Res 16: 362
Cossar JA, Hayes PC, O’ Carroll RE (1997) Benzodiazepine-like Substances and Hepatic Encephalopathie. Implications for treatment. CNS Drugs 8: 91–101
Costello RM (1975) Alcoholism treatment and evaluation: In search of methods. Int J Addict 10: 251–275
Cottler LB, Robins LN, Helzer JE (1989) The reliability of the CIDI-SAM: a comprehensive substance abuse interview. Br J Addict 84: 801–814
Courbon P, Chapoulaud J (1937) Hallucinations visuelles et unilatéralement auditives chez un alcoolique otopathe. Ann Méd-Psychol 95: 764–768
Cox BJ, Norton GR, Swinson RP, Endler NS (1990) Substance abuse and panic-related anxiety: A critical review. Behav Res Ther 28: 385–393
Crane DL (1977) Manic depressive disease in alcoholism. In: Seixas FA (ed) Currents in Alcoholism, Vol. 2. New York, Grune & Stratton
Croop RS, Chick J (1996) American and European Trials of Naltrexone. Paper given up the Symposion International Update: New Findings on Promising Medications. Joint Scientific Meeting 8th ISBRA Congress and RSA Meeting. Washington, June 25, 1996
Croop RS, Faulkner EB, Labriola DF (1997) The safety profile of naltrexone in the treatment of alcoholism. Results from a multicenter usage study. Arch Gen Psychiatry 54: 1130–1135
Cutting J (1987) The phenomenology of acute organic psychosis: comparison with acute schizophrenia. Br J Psychiatry 151: 324–332
Dettling M, Heinz A, Dufeu P, Rommelspacher H, Gräf K-J, Schmidt LG (1995) Dopaminergic responsivity in alcoholism: trait, state, or residual marker? Am J Psychiatry 152: 1317–1321
Deutsche Gesellschaft für Psychiatrie, Psychotherapie and Nervenheilkunde (DGPPN, 1997): Die Behandlung psychischer Erkrankungen in Deutschland, Positionspapier zur aktuellen Lage and zukünftigen Entwicklung; Berlin, Heidelberg, New York: Springer
Dixon L, Weiden PJ, Haas G, Sweeney J, Frances AJ (1992) Increased tardive dyskinesia in alcohol-abusing schizophrenic patients. Compr Psychiatry 33: 121–122
Dongier M, Vachon L, Schwartz G (1991): Bromocriptine in the treatment of alcohol dependence. Alcohol Clin Exp Res 15: 970–977
Doss MO, Sieg I (1995) Alkohol und Porphyrinstoffwechsel. In: Seitz HK, Lieber CS, Simanowski UA (Hrsg): Handbuch Alkohol Alkoholismus Alkoholbedingte Organschäden. Leipzig Heidelberg: Johann Ambrosius Barth: 167–189
Dufue P, Kuhn HS, Schmidt LG (1995) Prüfung der Gütekriterien einer deutschen Fassung des Tri-Dimensional-Personality-Questionnaire (TPQ), von Cloninger bei Alkoholabhängigen. Sucht 41: 359–407
Duke PJ, Pantelis C, Barnes THE (1994) South Westminster Schizoprenia Survey. Alcohol use and its relationship to symptoms, tardive dyskinesia and illness onset. Br J Psychiatry 164: 630–636
Easton C, Meza E, Mager D, Ulüg B, Kilic C, Gögüs A, Babor TF (1997) Test-retest reliability of the alcohol and drug use disorder sections of the schedules for clinical assessment in neuropsychiatry (SCAN). Drug and Alcohol Depend 47: 187–194
Edwards G, Gross M (1976): Alcohol dependence: provisional description of clinical syndrome. Br Med J 1: 2058–2061
Edwards G, Gross MM, Keller M, Moser J, Room R (1977) Alcohol-related disabilities. WHO offset publication no. 32; Genf
Egberts EH (1993) Hepatische Enzephalopathie. In: Schüttler R (Hrsg) Organische Psychosyndrome. Tropon-Symposion Bd VIII. Berlin Springer, Heidelberg New York, S 183–194
Emrick CD (1975) A review of psychologically oriented treatment of alcoholism: II. The relative effectiveness of different treatment approaches and the relative effectiveness of treatment versus no treatment. J Stud Alcohol 36: 88–108
Ewusi-Mensah I, Saunders JB, Wodak AD, Murray RM, Williams R (1983) Psychiatric morbidity in patients with alcoholic liver disease. Br Med J 287: 1417–1419
Fagius J, Osterman PO, Wiholm B-E (1985) Guillain-Barré syndrome following zimelidine treatment. J Neurol Neurosurg Psychiatry 48: 65–69
Fawcett J, Clark DC, Aagesen CA et al. (1987) A double-blind, placebo-controlled trial of lithium carbonate therapy for alcoholism. Arch Gen Psychiatry 44: 248–256
Ferenci P, Grimm G, Meryn S et al. (1989) Successful long-term treatment of portal-systemic encephalopathy by the benzodiazepine antagonist flumazenil. Gastroenterology 96: 240–224
Fett A (1996) Finanzierungssituation der ambulanten Beratungs-, Behandlungsstellen. In: Deutsche Hauptstelle gegen die Suchtgefahren (Hrsg) Jahrbuch Sucht 1997. Gesthacht: Neulandverlag, 153–161
Feuerlein W, Küfner H (1989) A prospective multicenter study on inpatient treatment for alcoholics: 18- and 48-months follow-up (Munich Evaluation for Alcoholism Treatment, MEAT). Eur Arch Psychiatry Neurol Sci 239: 144–157
Feuerlein W, Küfner H, Soyka M (1998) Alkoholismus - Mißbrauch und Abhängigkeit. 5. Auflage, Stuttgart: Thieme
Feuerlein W, Ringer CH, Küfner H, Antons K (1977) Diagnose des Alkoholismus. Der Münchner Alkoholismustest (MALT). Muench Med Wochenschr 119: 1275–1282
Feuerlein W., Dittmar F., Soyka M. (1999): Wenn Alkohol zum Problem wird. Stuttgart. Trias Verlag.
Fichter M (1997) Epidemiologie von Alkoholmißbrauch und Abhängigkeit. In: Soyka M, Möller HJ (Hrsg) Alkoholismus als psychische Störung. Berlin Heidelberg New York: Springer: 1–11
Fichter MM (1990a) Verlauf psychischer Erkrankungen in der Bevölkerung. Berlin Heidelberg New York Tokyo: Springer
Fichter MM (1990b) Prävalenz von Alkoholabusus und -abhängigkeit in der Bevölkerung. In: Fichter MM (Hrsg): Verlauf psychischer Erkrankungen in der Bevölkerung. Berlin Heidelberg New York Tokyo: Springer: 73–83
Fichter MM, Frick U (1992) Therapie und Verlauf von Alkoholabhängigkeit. Springer, Berlin Heidelberg New York
Fichter MM, Narrow WE, Roper MT et al. (1996) Prevalence of mental illness in Germany and the United States. Comparison of the upper bavarian study and the epidemiologic catchment area program. J Nerv Ment Dis 184: 598–606
Fichter MM, Weyerer S, Dilling H (1989) The upper Bavarian studies part II: The 5-year follow-up study in the Upper Bavaria. Acta Psychiatr Scand 348: 131–140
Finelli A, Benos J, Schremmer D (1997) Medivitan (Vitamin B6, Vitamin B12, Folsäure) bei Alkoholkranken in der Rehabilitation. Sucht: 43: 430–435
Fleischhacker WW, Günther V, Barnas Ch, Lieder F, Miller C (1986) Piracetam in alcoholic organic mental disorders: a placebo controlled study comparing two dosages. Int J Psychopharmacol 1: 210–215
Fornazzari L, Carlen PL (1982) Transient choreiform dyskinesias during alcohol withdrawal. Can J Med Sci 9: 89–90
Fuller RK, Branchey L, Brightwell DR, Derman RM, Emrick CD, Iber FL, James KE, Lacoursiere RB, Lee KK, Lowenstamm I, Manny I, Neiderhiser D, Nocks S, Shaw JJ (1986) Disulfiram treatment of alcoholism: a Veterans Aministration cooperative study. JAMA 256: 1449–1455
Gallimberti L, Canton G, Gentile N et al. (1989) Gamma-hydroxybutyric acid for treatment of alcohol withdrawal syndrome. Lancet II: 787–789
Gallimberti L, Ferri M, Ferrara SD, Fadda F, Gessa GI (1992) Gamma-Hydroxybutyric acid in the treatment of alcohol dependence: A double blind study. Alcohol Clin Exp res 16: 673–676
Gastpar M et al (1998) Vortrag auf dem 8. Central European Neuropsychopharmacological Symposion. Wien, 28.8.1998
Gawin FH, Allen D, Humblestone B (1989) Outpatient treatment of crack cocaine smoking with flupenthixol decanoate. Arch Gen Psychiatry 46: 322–325
Gawin FH, Khalsa-Denison M, Jatlow P (1996) Flupenthixol-Induced aversion to crack cocaine. New Engl J Med 334: 1340–1341
George DT, Adinoff B, Ravitz B, Nutt DJ, DeJong J, Berrettini W, Mefford IN, Costa E, Linnoila M (1990) A cerebrospinal fluid study of the pathophysiology of panic disorder associated with alcoholism. Acta Psychiatr Scand 82: 1–7
Gerra G, Caccauari R, Delsignore R, Bocchi R, Fertonani G, Passeri M (1992) Effects of Fluoxetine and Ca-Acetyl-Homotagrinate on Alcohol intake in Familial and nonfamilial Alcoholic Patients. Curr Ther Res 52: 291–295
Gessa GL, Mononi F, Collo M, Vargiu L, Mereu G (1985) Low doses of ethanol activate dopaminergic neurons in the ventral tegmental area. Brain Res 348: 201–203
Gilg T, Deinl I, Grundner H, Soyka M (1995) Stellenwert von Begleitstoffanalytik (Methanol, Isopropanol) und CD-Transferrin (CDT) in der Alkoholismusdiagnostik. In: Soyka M (Hrsg): Biologische Alkoholismusmarker. Weinheim London: Chapman & Hall 45–91
Gimsing P, Melgaard B, Andersen K, Vilsstrup H; Hippe E (1989) Vitamin B12 and folate function in chronic alcoholic men with peripheral neuropathy and encephalopathy. J Nutr 119: 416–424
Gish RG, Lee AH, Keeffe EB, Rome H, Concepcion W, Esquivel CO (1993) Liver transplantation for patients with alcoholism and end-stage liver disease. Am J Gastroenterol 88: 1337–1342
Glaeske G (1992) Auf Heller und Pfennig - Kosten und Nutzen der Suchtkrankenversorgung. In: Wienberg G (Hrsg) Die vergessene Mehrheit: zur Realität der Versorgung alkohol- und medikamentenabhängiger Menschen. Bonn: Psychiatrieverlag, 69–80
Glass IB (1989a) Alcohol hallucinosis: a psychiatric enigma. 1. The development of an idea. Br J Addict 84: 29–41
Glass IB (1989b) Alcohol Hallucinosis: a psychiatric enigma - 2. Follow-up Studies. Br J Addict 84: 151–164
Glen AIM, Glen EMT, Horrobin DH, Manku MS, Miller J, Will S, MacDonell LEF (1989) Essential Fatty Acids in Alcoholic Hallucinosis and Schizophrenia. Amsterdam Oxford New York: Excerpta Medica: 778 (Abs. No 3039)
Glue P, Nutt D (1990) Overexcitement and Disinhibition. Dynamic Neurotrans- mitter Interactions in Alcohol Withdrawal. Br J Psychiatry 157: 491–499
Goebell H, Bode C, Bastian R, Strohmeyer G (1970): Klinische asymptomatische Funktionsstörungen des exokrinen Pankreas bei chronischen Alkoholikern. Dtsch Med Wschr 95: 808
Gooday R, Hayes PC, Bzeizi K et al. (1995) Benzodiazepine receptor antagonism improves reaction time in latent hepatic encephalopathy. Psychopharmacology 119: 295–298
Goodwin FK, Jamison KR (1990) Manic depressive illness. New York: Oxford University Press
Gorelick PB (1989) Status of alcohol as a risk factor for stroke. Stroke 20: 1907–1610
Gottesleben A, Willemsen D, Wolf C (1995) Retardiertes Carbamazepin in der Therapie des alkoholischen Prädelirs. Akt Neurol 22: 60–65
Graham JR, Woodhouse D, Read FH (1971) Massive thiamine dosage in an alcoholic with cerebellar cortical degeneration. Lancet 2:107
Grimm G, Ferenci P, Katzenschlager R et al. (1988) Improvement of hepatic encephalopathy treated with flumazenil. Lancet 17: 1392–1394
Gross MM, Halpert E, Sabot L, Polizos P (1963) Hearing disturbances and auditors hallucinations in the acute alcoholic psychoses. I. Tinnitus: incidence and significance. J Nerv Ment Dis 137: 455–465
Gross MM, Hastey JM (1975) A note on REM rebound during experimental alcohol withdrawal in alcoholics. Adv Exp Med Biol 59: 509–521
Gross MM, Hastey JM (1976) Sleep disturbances in alcoholism. In: Tarter RE, Sugerman AA (eds) Alcoholism. Addison-Wessley, London, pp 257–307
Gross MM, Rosenblatt SM, Malenowski B, Broman M, Lewis ERN (1971) A Factor Analytic Study of the Clinical Phenomena in the Acute Alcohol Withdrawal Syndromes. Toronto: Press of Addiction Res. Foundation
Grüngreiff K (1996) Zinkmangel and hepatische Enzephalopathie. Med Welt 47: 23–27
Gyr K, Meier R, Haussler P et al. (1996) Evaluation of the efficacy and safety of flumazenil in the treatment of portal systemic encephalopathy: a double blind, randomised, placebo controlled mulitcentre study. Gut 39: 319–24
Hall W, Saunders JB, Babor TF, Aasland OG, Amundsen A, Hodgson R, Grant M (1993) The structure and correlates of alcohol dependence: WHO collaborative project on early detection of persons with harmful alcohol consumption. - III Addiction, 88: 1627–1636
Helzer JD, Pryzbeck TR (1988) The cooccurence of alcoholism with other psychiatric disorders in the general population and its impact on treatment. J Stud Alcohol 49: 219–224
Helzer JE, Canino GJ, Hwu H-G et al. (1988) Alcoholism: A Cross-National Comparison of Population Surveys with the Diagnostic Interview Schedule. In Rose RM, Barrett J (eds.) Alcoholism: origins and outcome. Raven Press, New York, pp 31–47
Hendel J, Dam M, Gram L, Winkel P, Jorgensen I (1984) The effects of carbamazepine and valproate on folate metabolism in man. Acta Neurol Scand 69: 226–231
Herz A (1997) Endogenous opioid systems and alcohol addiction. Psychopharmacol 129: 99–111
Herzmann CE (1989) Zum Stellenwert des Carbamazepin bei stationärer Entzugsbehandlung von Alkoholabhängigen. In: Müller-Oerlinghausen B, Haas S, Stoll KD (Hrsg) Carbamazepin in der Psychiatrie. Thieme, Stuttgart New York: 63–68
Hietala J, West C, Syvälahti E, Nägren K, Lehikoinen P, Sonninen P, Ruotsalainen U (1994): Striatal D2 dopamine receptor binding characteristics in vivo in patients with alcohol dependence. Psychopharmacology 116: 285–290
Hillman RS, Steinberg SE (1982) The effects of alcohol on folate-metabolism. Ann Ref Med 33: 345
Hirschfeld RMA; Kosier T, Keller MB, Lavori PW, Endicott J (1989) The influence of alcoholism on the course of depression. J Affective Disord 16: 151–158
Holly A, Türk D, Nelson CB, Pfister H, Wittchen H-U (1997) Prävalenz von Alkoholkonsum, Alkoholmißbrauch and -abhängigkeit bei Jugendlichen and jungen Erwachsenen. Z Klin Psychol 26: 171–178
Howard L, Fahy T (1997) Liver-transplantation for alcoholic liver-disease. Br J Psychiatry 171: 497–500
Hrubec Z, Omenn GS (1981) Evidence of genetic disposition to alcoholic cirrhosis and psychosis: Twin concordances for alcoholism and its biological end points by zygosity among male veterans. Alcohol Clin Exp Res 5: 207–215
Hughes JC, Cook CH (1997) The Efficacy of Desulfiram: A Review of Outcome Studies. Addiction 92: 381–395
Hüllinghorst (1996) Versorgung Suchtkranker in Deutschland. In: Deutsche Hauptstelle gegen die Suchtgefahren (Hrsg) Jahrbuch Sucht. Gesthacht: Neulandverlag, 128–142
Imperato A, Di Chiara G (1986): Preferential stimulation of dopamine release in the nucleus accumbens of freely moving rats by ethanol. J Pharmacol Exp Ther 239: 219–228
Ishak KG, Zimmerman HJ, Ray MB (1991) Alcoholic Liver Disease: Pathologic, Pathogenetic and Clinical Aspects. Alcohol Clin Exp Res 15: 45–66
Ivanets NN (1995) The Use of Tianeptine in Treating Alcoholism. Alcohol Clin Exp Res 19 (Suppl.): 17A (Abstract-Nr. 80A)
Jacobi C, Brand-Jacobi J, Marquardt F (1987) Die Göttinger Abhängigkeitsskala (GABS): Ein Verfahren zur differentiellen Erfassung der Schwere der Alkoholabhängigkeit. Suchtgefahren 33: 23–36
Jellinek EM (1960) The disease concept of alcoholism. New Haven: Hillhouse
Johanson E (1961) Acute hallucinosis, paranoic reactions and schizophrenia as psychosis in alcoholic patients. Acta Societatis Medicorum Upsaliensis 66: 105–128
John U, Veltrup C, Schnofl A, Bunge S, Wetterling T, Dilling H (1992) Entwicklung eines Verfahrens zur Erfassung von Ausprägungen der Alkoholabhängigkeit aufgrund von Selbstaussagen: die Lübecker Alkoholabhängigkeitsskala (LAS). Sucht 38: 291–303
John U, Hapke U, Rumpf H-J (1997) Gesundheitsversorgung und Sekundärprävention der Abhängigkeit von psychotropen Substanzen. In: Watzel H, Rockstroh B (Hrsg) Abhängigkeit und Mißbrauch von Alkohol und Drogen. Göttingen Bern Toronto Seattle: Hogrefe: 185–199
John U, Hapke U, Rumpf H-J, Hill A & Dilling H (1996): Prävalenz und Sekundärprävention von Alkoholmißbrauch und -abhängigkeit in der medizinischen Versorgung. Band 71, Schriftenreihe des Bundesministeriums für Gesundheit. Baden-Baden: Nomos
Johnson CD, Bernard JP (1995) Pathophysiologie der alkoholinduzierten Pankreatitis. In: Handbuch Alkohol Alkoholismus Alkoholbedingte Organschäden. Leipzig Heidelberg: Johann Ambrosius Barth: 261–272
Julien (1997) Drogen und Psychopharmaka. Heidelberg Berlin Oxford: Spektrum, Akademischer Verlag
Junge B (1995) Alkohol. In: Deutsche Hauptstelle gegen die Suchtgefahren (Hrsg) Jahrbuch Sucht 96. Geesthacht, Neuland: 9–22
Juvela S (1992) Alcohol consumption as a risk factor for poor outcome after aneurysmal subarachnoid haemorrhage. Br Med J 304: 1663–1667
Kathmann N, Soyka M, Bickel M, Engel R (1996) ERP changes in alcoholics with and without alcohol psychosis. Biol Psychiatry 39: 873–881
Kawamura M, Shiota J, Yagishita T, Hirayama K (1985) Marchiafava-Bignami disease: Computed tomographic scan and magnetic resonsance imaging. Ann Neurol 18: 103
Keller MB, Lavori PW, Coryell W et al. (1986) Differential outcome of pure mania, mixed/cycling, and pure depressive episodes in patients with bipolar illness. JAMA 255: 3138–3142
Kellner R, Rada RT (1979) Pharmacotherapy of personality disorders. In: Davis JM, Greenblatt D (eds) Psychopharmacology update: new and neglected areas. New York, Grune & Stratton, pp 29–63
Kendler KS (1985) A twin study of individuals with both schizophrenia and
Kielstein U (1997) Tagesklinische Behandlung Alkoholabhängiger. Nervenheilkunde 6: 390–395
Kielstein V: Alkoholentzug unter tagesklinischen Bedingungen. In: Wagner HB, Krausz M, Schwoon DR (Hrsg) Tagesklinik für Suchtkranke (1996). Freiburg: Lambertus: 41–47
Kielstein V (1991) Indikationskriterien und Prinzipien der ambulant-tagesklinischen Therapie von Alkoholkranken. Sucht 37: 114–120
Klein C-P, Kalk J-F, Witting D, Klein C-G (1993) Einfluß von Alkohol auf die Hämodynamik der Pfortader bei nutritiv-toxischer Leberzirrhose. Dtsch Med Wschr 118: 89–93
Knudsen P, Vilmar T (1984) Cannabis and neuroleptic agents in schizophrenia. Acta Psychiatr Scand 69: 162–174
Körkel J, Schindler C (1996) der Kurzfragebogen zur Abstinenzzuversicht (KAZ35) - ein Instrument zur Erfassung der abstinenzorientierten Kompetenzzuversicht Alkoholabhängiger. Sucht 42: 156–166
Kranzler HR, Burleson JA, Del Boca FK, Babor TF, Korner P, Brown J, Bohn MJ (1994) Buspirone Treatment of Anxious Alcoholics. A Placebo-Controlled Trial. Arch Gen Psychiatry 51: 720–731
Kranzler HR, Burleson JA, Korner P, Del Boca FK, Bohn MJ, Brown J, Liebowitz N (1995) Placebo-controlled trial of fluoxetine as an adjunct to relapse prevention in alcoholics. Am J Psychiatry 152: 391–397
Kranzler HR, Del Boca FK, Korner P, Brown J (1990) Fluvoxamine is poorly tolerated by alcoholics. In: Naranjo CA, Sellers EM (eds) Novel pharmacological interventions for alcoholism. Berlin Heidelberg New York: Springer: 304–308
Kranzler HR, Myers RE (1989) An open trial of buspirone in alcoholics. J Clin Psychopharmacol 9: 379–380
Krasner N, Moore MR, Goldberg A, Booth JCD, Frame AH, McLaren AD (1976) A trial of fenfluramine in the treatment of the chronic alcoholic patient. Br J Psychiatry 128: 346–353
Krasney OE (1987) Sozialrechtliche Vorschriften bei der Betreuung Suchtkranker, 5. Auflage, Kassel: Nicol.
Krasney OE (1989) Rechtsgrundlagen bei der Behandlung der Suchtkrankheit. In Schied HW, Heimann H, Maier K (Hrsg): Der chronische Alkoholismus. Stuttgart New York: Gustav Fischer, S. 245–250
Krystal JH, Leaf PJ, Bruce ML, Charney DS (1992) Effects of age and alcoholism on the prevalence of panic disorder. Acta Psychiatr Scand 85: 77–82
Krystal JH, Webb E, Cooney N, Kranzler HR, Charney DS (1994) Specificity of ethanollike effects elicited by serotonergic and noradrenergic mechanisms. Arch Gen Psychiatry 51: 898–911
Küfner A (1981): Ambulante Therapie von Alkoholabhängigen. In: Keup W (Hrsg) Behandlung der Sucht und des Mißbrauchs chemischer Stoffe. Stuttgart: Thieme: 73
Küfner H, Feuerlein W, Huber M (1988) Titel? Suchtgefahren 34: 157
Kunkel E (1987) Kontrolliertes Trinken und Abstinenz - Therapieziele bei Alkoholikern. Suchtgefahren 33: 389–404
Kurella B, Heitmann A, Dormann S, Meister K (1990b) Besonderheiten des Schlafes bei abstinenten Alkoholikern. Vergleich alkohol- und altersbedingter Tiefschlafreduktion. Z EEG EMG 21: 157–160
Kurella B, Heitmann A, Dornmann S (1990a) Schlafpolygraphische Untersuchungen und subjektive Schlafeinschätzungen bei abstinenten Alkoholikern. Z Klin Med 45: 1519–1522
Kushner MG, Sher KJ, Beitman BD (1990) The relationship between alcohol problems and the anxiety disorders. Am J Psychiatry 147: 685–695
Laitinen K, Lamberg-Allard C, Tunninen R, Karonen SL, Taehtelae R, Ylikhahri R, Vaelimaeri (1991) Transient Hypoparthyroidism During Acute Ethanol Intoxication. N Engl. 9 Med 324: 721–727
Langlais PJ, Mair RG, Whalen PJ, McCourt W, McEntee WI (1988) Memory effect of DL-threo-3,4-dihydroxyphenylserine (DOPS) in human Korsakow’s disease. Psychopharmacology Berl. 95: 250–254
Langlais PJ, Mair RG (1990) Protective effects of the glutamate antagonist MK-801 on pyrithiamine-induced lesions and amino acid changes in rat brain. J Neurosci 10: 1664–1674
Längle G, Schäfer D, Mann K (1994) Der Langzeitverlauf bei Alkoholikern - 16 Jahre nach der Therapie. Vortrag auf der 10. Wissenschaftlichen Tagung der Dt. Gesellschaft für Suchtforschung und Suchttherapie. Tübingen, 06.-09.04.1994.
Langohr HD, Tröster H, Zimmermann CW (1989) Alkoholenzymopathie der Muskulatur. In: Schied HW, Heimann H, Mayer K (Hrsg) Der chronische Alkoholismus. Grundlagen, Diagnostik, Therapie. Stuttgart New York: Gustav Fischer: 229–238
Larson EW, Olincy A, Rummans TA, Morse RM (1992) Disulfiram treatment of patients with both alcohol dependence and other psychiatric disorders: A review. Alcohol Clin Exp Res 16: 125–130
Laureno R, Karp BI (1988) Pontine and extrapontine myelinolysis following rapid correction of hyponatraemia. Lancet 1: 1439
Laux G, Reimer F (1979) Zur Pathogenese des alkoholischen Eifersuchtswahns. Nervenarzt 50: 299–301
Lefebvre d’Amour M, Shahani BT, Young DR, Bird KT (1979) The importance of studying sural nerve conduction and late responses in the evaluation of alcoholic subjects. Neurology 29: 1600–1604
Lhuintre JP, Daoust M, Moore N, Chretien P, Saligaut C, Tran G, Boismare F, Hillemand B (1985) Ability of calcium bis-acetyl homotaurine, a GABA agonist, to prevent relapse in weaned alcoholics. Lancet I: 1014–1016
Lhuintre JP, Moore N, Tran G, Steru L, Langrenon S, Daoust M, Parot Ph, Ladure Ph, Libert C, Boismare F, Hillemand B (1990) Acamprosate appears to decrease alcohol intake in weaned alcoholics. Alcohol Alcohol 25: 613–622
Lindberg S, Agren G (1988) Mortality of Swedish Hospitalized Alcoholics. Br J Addict 83: 1193–1200
Littleton J (1995) Acamprosate-how does it work? Addiction 90: 1179–1188
Lôo H, Malka R, Defrance R, Barrucand D, Benard JY, Niox-Rivière H, Raab A, Sarda A, Vachonfrance G, Kamoun A (1988) Tianeptine and amitryptiline. Controlled double-blind trial in depressed alcoholic patients. Neuropsychobiology 19: 79–85
Lucey JV, Dinan TG (1992) Orofacial dyskinesia and the alcohol dependence syndrome. Psychol Med 22: 79–83
Lucey MR, Beresford TP (1992) Alcoholic liver disease: to transplant or not transplant? Alcohol Alcoholism 27: 103–108
Mair RG, McEntee WJ (1986) Cognitive enhancement in Korsakow’s psychosis by clonidine: a comparison with L-dopa and ephedrine. Psychopharmacology Berl. 88: 374–80
Majumdar SK (1990) Chlormethiazole: Current status in the treatment of the acute ethanol withdrawal syndrome. Drug Alcohol Depend 27: 201–207
Malcolm R, Anton RF, Randall CL, Johnston A, Brady K, Thevos A (1992) A placebo-controlled trial of buspirone in anxious inpatient alcoholics. Alcohol Clin Exp Res 16: 1007–1013
Malec E, Malec T, Gagné MA, Dongier M (1996) Buspirone in the Treatment of Alcohol Dependence: A Placebo-Controlled Trial. Alcohol Clin Exp Res 20: 307–312
Malec E, Malec T, Dongier m (1996) Efficacy of Buspirone in Alcohol Dependence: A Review. Alcohol Clin Exp Res 20: 853–858
Malka R, Loo H, Ganry H, Souche A, Marey C, Kamoun A (1992) Long-term administration of tianeptine in depressed patients after alcohol withdrawal. Br J Psychiatry 160: 66–71
Manikant S, Tripathi BM, Chavan BS (1993) Loading dose diazepam therapy for alcohol withdrawal state. Ind J Med Res 98: 170–173
Mann K (1992) Alkohol und Gehirn, Springer, Berlin Heidelberg
Marcel LNS (1847) De la folie causée par l’abus des boissons alcooliques, thèsis. Paris, Imprimeur de la Faculté de Médecin. Rinoux
Marsano L, McCain CJ (1992) Nutritional support in alcoholic lever disease. In: Watson RR, Watzl B (eds): Nutrition and alcohol. Boca Raton: CRC Press: 385–402
Martin PR, Adinoff B, Eckardt MJ Stapleton JM, Bone GA, Rubinow DR, Lane EA, Linnoila M (1990) Effective pharmacotherapy of alcoholic amnestic disorder with fluvoxamine. Preliminary findings [see comments]. Arch Gen Psychiatry 46: 617–621
Martin PR, Adinoff B, Lane E, Stapleton JM, Bone GA, Weingartner H, Linnoila M, Eckardt MJ (1995) Fluvoxamine treatment of alcoholic amnestic disorder. Eur Neuropsychopharmacol. 5: 27–33
Mason BJ, Kocsis JH (1991) Desipramine treatment of alcoholism. Psychopharmacology Bull 27: 155–161
Mason BJ, Kocsis Jh, Ritvo EC, Cutler RB (1996) A Double-blind, Placebo-Controlled Trial of Desipramine for Primary Alcohol Dependence Stratified on the Presence or Absence of Major Depression. JAMA 275: 761–767
Mason BJ, Ritvo EC, Morgan RO, Salvato FR, Goldberg G, Welch B, Mantero-Atienza E (1994) A double-blind, placebo-controlled pilot study to evaluate the efficacy and safety of oral nalmefene HCL for alcohol dependence. Alcohol Clin Exp Res 18: 1162–1167
Maylath E, Seidel J (1997) Analyse der psychiatrischen Krankenhausfälle in Hamburg 1988, 1994 - Entwicklungstrends, Versorgungslücken and -Perspektiven. Gesundheitswesen 59: 423–433
Mayo-Smith, MF for the American Society of Addiction Medicine, Working Group on Pharmacological Management of Alcohol Withdrawal (1997) Pharmacological Management of Alcohol Withdrawal. A Meta-analysis and Evidence-Based Practice Guideline. JAMA 278: 144–151
Mc Lellan AT, Kushner H, Metzger D, Peters S, Smith I, Grissim G, Pettinati M, Argerou M (1992): The fifth edition of the addiction severity index. Substance Abuse Treatment 9: 199–213
McCaul ME (1996) Efficacy of naltrexone for alcoholics with and without comorbid opiate or cocaine dependence. Paper given at the symposion “International Update: New Findings on Promising Medications”. Joint Scientific Meeting 8th ISBRA congress and RSA meeting. Washington, June 25, 1996
McEntee WJ, Mair RG (1980) Memory enhancement in Korsakow’s psychosis by clonidine: further evidence for a noradrenergic deficit. Ann Neurol. 7: 466–470
McEntee WJ, Mair RG, Langlais PJ (1981) Clonidine in Korsakow disease: patho- physiologic and therapeutic implications. Prog Clin Biol Res. 71: 211–223
McGrath PJ, Nunes EL, Stewart JU, Goldman D, Agogti L, Oleder-Welikson K, Quitkin FM (1996) Imipradime Treatment of alcoholics with Primart Depression. Arch Gen Psychiarty 53:232–240
McKay JR, Alterman AI, McLellan AT, Snider EC (1994) Treatment Goals, Continuity of Care, and Outcome in a Day Hospital Substance Abuse Rehabilitation Program. Am J Psychiatry 151: 254–259
Meister P (1990) Alkohol-bedingte Kardiomyopathien. Schlägt das Münchner Bierherz noch? Munch Med Wschr 132: 22–26
Michel H, Solere NM, Granier P et al. (1980) Treatment of cirrhotic encephalo- pathy with L-dopa: a controlled clinical trial. Gastroenterology 9: 207–211
Miller WR, Hester RK (1986) The effectiveness of alcoholism treatment. What Research reveasl. In: Miller WR, Heather N (ed): Treating addictive behaviors. Processes of change. New York: Plenum Press: 121–174
Moak DH, Anton RF (1995) An opel-label trial of Sertraline in Depressed Alco- holic Outpatients. Alcohol Clin Exp Res 19 (Suppl.): 17A (Abstract-Nr. 82)
Moffoot A, O’Carroll RE, Murray C, Dougall N, Ebmeier K, Goodwin GM (1994) Clonidine infusion increases uptake of 99mTc-Exametazime in anterior cingulate cortex in Korsakow’s psychosis. Psychol Med. 24: 53–61
Monti JM, Alterwain P (1991) Ritanserin decreases alcohol intake in chronic alcoholics. Lancet 337: 360
Mooney HB (1965) Pathologic jealousy and psychochemotherapy. Br J Psychiatry 111: 1023–1042
Moore R, Bone LR, Geller G, Momon JA, Stokes EJ & Levone DM (1989) Prevalence, detection, and treatment of alcoholism in hospitalized patients. JAMA 261: 403–407
Morel F (1939) Une forme anatomoclinique particulière dé 1 alcoolisme chronique. Sclerose cortical laminaire alcoolique. Rev Neurol 71: 280
Morgan J, McSharry K, Sireling L (1990) Comparison of a system of staff prompting with a programmable electronic diary in a patient with Korsakow’s sysdrome. Int J Soc Psychiatry 36: 226–229
Mueller TI, Stout RL, Rudden S, Brown RA, Gordon A, Dolomon DA, Recupero PR (1997) A Double-Blind, Placebo-Controlled Pilot Study of Carbamazepine for the Treatment of Alcohol Dependence. Alcohol Clin Exp Res 21: 86–92
Mueser KT, Bellack AS, Blanchard JJ (1992) Comorbidity of schizophrenia and substance abuse: Implications for treatment. J Consult Clin Psychol 60: 845–856
Mueser KT, Yarnold PR, Levinson DF, Singh H, Bellack AS, Kee K, Morrison RL, Yadalam KG (1990) Prevalence of Substance Abuse in Schizophrenia: Demographic and Clinical Correlates. Schizophrenia Bull 16: 31–56
Mullen K, Szauter K, Kaminsky-Russ K (1990) Endogenous benzodiazepine activity in body fluids of patients with hepatic encephalopathy. Lancet 336: 81–83
Naber M, Franz W, Overbeck W (1991) Besonderheiten des Alkoholentzugsdelirs beim chirurgischen Patienten and Hinweise zur Behandlung. Chirurg 62: 133–137
Nalpas B, Feitelson M, Bréchot C, Rubin E (1995): Alcohol, Hepatotropic Viruses and Hepatocellular Carcinoma. Alcohol Clin Exp Res 19: 1089–1095
Naranjo C (1979) Psychotropic properties of the harmala alkaloids. In: Efron DH, Holmstedt B, Kline NS (eds): Ethnopharmacologic search for psychoactive drugs. Raven Press, New York, pp 385–391
Naranjo CA, Kadlec KE, Sanhuezza P, Sellers EM (1990) Fluoxetine differentially alters alcohol intake and other consumatory behaviors in problem drinkers. Clin Pharmacol Ther 47: 490–498
Naranjo CA, Poulos CX, Bremner KE, Lanctôt KL (1992) Citalopram decreases desirability, liking, and consumption of alcohol in alcohol-dependent drinkers. Clin Pharmacol Ther 51: 729–739
Naranjo CA, Poulos CX, Lanctôt L, Bremner KE, Kwok M, Umana M (1995) Ritanserin, a central 5-HT2 antagonist, in heavy social drinkers: desire to drink, alcohol intake and related effects. Addiction 90: 893–905
Naranjo CA, Sellers EM, Roach CA, Woodley DV, Sanchez-Craig M, Sykora K (1984) Zimelidine-induced variations in alcohol intake by non-depressed heavy drinkers. Clin Pharmacol Ther 35: 374–381
Naranjo CA, Sellers EM, Sullivan JT, Woodley DV, Kadlec K, Sykora K (1987) The serotonine uptake inhibitor citalopram attentuates ethanol intake. Clin Pharmacol Ther 41: 266–274
Neiman J, Borg S, Wahlund LO (1988) Parkinsonism nd dyskinesias during ethanol withdrawal. Br J Addict 83: 437–439
Neundörfer B (1986) Neurologische Folgeerscheinungen des Alkoholismus. Med Welt 23: 766–770
Nunes EV, McGrath PJ, Quitkin FM, Stewart JW, Harrison W, Tricamo E, Ocepete-Welikson K (1993) Imipramine treatment of alcoholism with comorbid depression. Am J Psychiatry 150: 963–965
O’Carroll RE, Moffoot A, Ebmeier KP, Murray C, Goodwin GM (1993): Korsakow’s syndrome, cognition and clonidine. Psychol Med. 23: 341–347
O’Carroll RE, Moffoot AP, Ebmeier KP, Goodwin GM (1994) Effects of fluvoxamine treatment on cognitive functioning in the alcoholic Korsakow syndrome.Psychopharmacology Berl. 116: 85–88
Oh SJ (1976) Alcoholic myopathy, electrophysiological study. Electromyogr Clin Neurophysiol 16: 205–218
Olbrich R, Watzl H, Völter M, Siedow H (1991) Lithium in der Behandlung chronischer Alkoholkranker mit zerebralen Schädigungen - eine kontrollierte Studie. Nervenarzt 62: 182–186
O’Malley SS (1995) Integration of Opioid Antagonists and Psychosocial Therapy in the Treatment of Narcotic and Alcohol Dependence. J Clin Pychiatry 56 (Suppl. 7): 30–38
O’Malley SS, Jaffe AJ, Chang G, Rode S, Schottenfeld R, Meyer RE, Rounsaville B (1996) Six-Month Follow-up of Naltrexone and Psychotherapy for Alcohol Dependence. Arch Gen Psychiatry 53: 217–224
O’Malley SS, Jaffe AJ, Chang G, Schottenfeld RS, Meyer RE, Rounsaville BJ (1992) Naltrexone and coping skills therapy for alcohol dependence: a controlled study. Arch Gen Psychiatry 49: 881–887
Paille FM, Guelfi JD, Perkins Ac, Royer RJ, Steru L, Parot P (1995) Double-blind randomized multicentre trial of acamprosate in maintaining abstinence from alcohol. Alcohol Alcohol 30: 239–247
Palsson A (1986) The efficacy of early chlormethiazole medication in the prevention of delirium tremens. A retrospective study of the outcome of different drug treatment strategies at the Helsingborg psychiatric clinics, 1975–1980. Acta Psychiatr Scand 73 (Suppl 329): 140–145
Peachey JE, Annis HM, Bornstein ER, Maglana SM, Sykora K (1989b): Calcium carbimide in alcoholism treatment. Part 2: medical findings o a short term, placebo-controlled, double-blind clinical trial. Br J Addict 84: 1359–1366
Peachey JE, Annis HM, Bornstein ER, Sykora K, Maglana SM, Shamai S (1989a) Calcium carbimide in alcoholism treatment. Part 1: a placebo-controlled, double-blind clinical trial of short-term efficacy. Br J Addict 84: 877–887
Peiffer J (1989) Neuropathologische Aspekte des chronischen Alkoholismus. In: Schied HW, Heimann H, Mayer K (Hrsg) Der chronische Alkoholismus. Gustav Fischer, Stuttgart New York, S 103–120
Peters DH, Faulds D (1994) Tiapride. A review of its pharmacology and therapeutic potential in the management of alcohol dependence syndrome. Drugs 47: 1010–1032
Petry J (1993) Alkoholismustherapie. Weinheim: Psychologie Verlags Union, Beltz
Pettinati HM, Haag, Belden P (1996) Ambulante versus stationäre Therapie bei Abhängigkeitserkrankungen: Neue Perspektiven. In: Mann K, Buchkremer G (Hrsg) Sucht - Grundlagen, Diagnostik, Therapie. Stuttgart Jena New York: Gustav Fischer Verlag: 265–273
Pettinati HM, Meyers K, Jensen JM, Kaplan F, Evans BD (1993): Inpatient vs outpatient treatment for substance dependence revisited. Psychiatr Q 64: 173–182
Pfeiffer WE, Fahrner EM, Feuerlein W (1987): Katamnestische Untersuchung von ambulant behandelten Alkoholabhängigen. Suchtgefahren 33: 309–320
Pfizer F, Schuchardt V, Heitmann R (1988) Die Behandlung schwerer Alkohol-delirien. Nervenarzt 59: 229–236
Poldrugo F (1997) Acamprosate treatment in a long-term community-based alcohol rehablitation programme. Addiction 92: 1537–1546
Poldrugo F, Chabac S, Lehert P (1994) Acamprosate in the long-term treatment of alcoholism: is ist use recommended within the psych-social approach? Alcohol Clin Exp Res 18: 43A (Abstr. N. 9.2)
Pollock BG (1982): Successful treatment of pathological jealousy with pimozide. Can J Psychiatry 27: 86–87
Pomier-Layrargues G, Giguere J, Lavoie J et al. (1994) Flumazenil in cirrhotic patients in hepatic coma: a randomised double-blind placebo-controlled crossover trial. Hepatology 19: 32–37
Pond SM, Becker CE, Vandervoort R, Phillips M, Bowler RM, Peck CC (1981) An evaluation of the effects of lithium in the treatment of cronic alcoholism. I. clinical results. Alcoholism 5: 247–251
Preuss UW, Schröter A, Soyka M (1997) Typologien der Alkoholkrankheit - ein kritischer Vergleich. Sucht 43: 92–103
Preuss UW, Soyka M (1997) Das Wernicke-Korsakow-Syndrom; Klinik, Pathophysiologie und therapeutische Ansätze. Fortschr Neurol Psychiatr 65: 413–420
Pulvirenti L, Koob GF (1994) Dopamine receptor agonists, partial agonists and psychostimulant addiction. Trends Pharmacol Sci 15: 374–379
Regier DA, Boyd JH, Burke JD, Rae DS, Myers JK, Kramer M, Robins LN, Lin KG, Karno M, Locke BZ (1988) One-month prevalence of mental disorders in the United States. Arch Gen Psychiatry 45: 977–986
Regier DA, Farmer ME, Rae DS, Locke BZ, Keith SJ, Judd LL, Goodwin FK (1990) Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA 264: 2511–2518
Ritola E, Mahnen L (1981) A double-blind comparison of carbamazepine and clomethiazole in the treatment of alcohol withdrawal syndrome. Acta Psychiatr Scand 64: 254–259
Robins LN, Helzer JE, Przybeck TR, Regier DA (1988) Alcohol disorders in the community: a report from the Epidemiologic Catchment Area. In: Rose RM, Barrett JE (eds) Alcoholism: origins and outcome. Raven Press, New York, pp 15–29
Roccatagliata G, Albano C, Maffini M, Farelli S (1980) Alcohol withdrawal syn- drome: treatment with trazodone. Int Pharmacopsychiatry 15: 105–110
Rogers RL, Meyer JS; Shaw TG et al. (1983) Reductions in regional cerebral blood flow associated with chronic consumption of alcohol. J Amer Geriatr Soc 31: 540–543
Rohner Hg, Berges W, Wienbeck M (1982) Clomethiazole tablets induce ulcers in the esophagus. Z Gastroenterologie 20: 469–473
Romach MK, Sellers EM, Kaplan HL, Somer G, Sobell MC, Sobell LC (1996) Efficacy of dexfenfluramine (DEX) in the traetment of alcohol dependence. Alcohol Clin Exp Res 20 (Suppl.): 90 (Abstract Nr. 520)
Rommelspacher H (1997) Neurobiologische Grundlagen der Alkoholabhängigkeit. In: Soyka M, Möller HJ (Hrsg): Alkoholismus als psychische Störung. Bayer ZNS Symposium XII. Berlin Heidelberg New York: Springer Verlag: 33–56
Rommelspacher H, Schmidt LG, May T (1991) Plasma Norharman (beta-Carboline) Levels are Elevated in Chronic Alcoholics. Alcohol Clin Exp Res 15: 553–559
Rössler W, Riecher-Rössler A, Meise U (1993) Von der stationären Langzeitentwöhnung zur ambulanten gemeindenahen Versorgung Alkoholkranker. Nervenheilkunde 12: 438–444
Roth J (1987) FTA-Fragebogen zur Klassifikation des Trinkverhaltens Alkoholabhängiger. Berlin: Psychodiagnostisches Zentrum
Rubenstein AE, Wineapel SF (1977) Acute hypokalemic myopathy in alcoholism. Arch Neurol 34: 553–555
Rubin E, Thomas AP (1992) Effects of Alcohol on the Heart and Cardiovascular System. In: Mendelson JM, Mello NK (eds): Medical Diagnosis and Treatment of Alcoholism. New York: McGraw-Hill: 263–287
Rumpf KW, Henze T, Kaiser H, Kein H, Spaar U Soballa U, Prange H, Henning HV, Scheler F (1986) Rhabdomyolyse als Komplikation des chronischen Alkoholismus. Dtsch Med Wschr 111: 379–382
Saitz R, Mayo-Smith MF, Roberts MS, Redmind HA, Bernard DR, Calkins DR (1994) Individualized treatment für alcohol withdrawal: a randomized double-blind controlled trial. JAMA 272: 519–23
Salloum I, Cornelius J, Thage EM, Daley D, Kirisci L, Spotts C (1998) Naltrexone Utility in Depressed Alcoholics. Psychopharmacol Bull 34: 111–115
Salvato FR, Mason BJ, Williams LD (1995) Sertraline Treatment of Depression concomitant with nalmefene treatment of alcoholism: a case study. Alcohol Clin Exp Res 19 (Suppl.): 17A (Abstract-Nr. 79)
Sass H, Soyka M, Mann K, Zieglgänsberger W (1996) Relapse prevention by acamprosate: results from a placebo controlled study on alcohol dependence. Arch Gen Psychiatry 53: 673–680
Sand P, Soyka M (1997) Substance Abuse in Clozapine-Treated Schizophrenics. U Neuropsychiatry Clin Neurosci 9: 626–627
Satel SL, Kosten TR, Schuckit MA, Fischman MW (1993) Should protracted withdrawal from drugs be included in DSM-IV? Am J Psychiatry 150: 695–704
Scheller R, Keller W, Funke J, Klein M (1984) Trierer Alkoholismusinventar (TAI) - Ein Verfahren zur Differentialdiagnose des Alkoholismus. Suchtgefahren 30: 12–14
Schilkrut R, Cabrera J, Morales E, Herrera L (1988) Neuroleptics in the Treatment of Drug Dependence in Schizophrenics: A Study with Flupenthixol Decanoate. Psychopharmacology 96 (Suppl): 342 (Abstract No 33.01.50)
Schmidt L (1997) Diagnostik von Alkoholmißbrauch und Alkoholabhängigkeit. In: Soyka M, Möller HI (Hrsg): Alkoholismus als psychische Störung. BayerZNS-Symposium XII. Berlin Heidelberg New York: Springer: 61–70
Schmidt LG, Kuhn S, Rommelspacher H (1997) Pharmacological effects of lisuride shorten, expectations to receive the drug prolong the latency of relapse in cleaned alcoholics. Pharmacopsychiat 30: 219
Scholz E, Diener CH (1989) Alkoholschäden an peripheren Nerven und Kleinhirn. In: Schied HW, Heimann H, Mayer K (Hrsg): Der chronische Alkoholismus. Gustav Fischer, Stuttgart New York: 141–154
Scholz H (1980) Das Ausfallsyndrom nach Unterbrechung der Alkoholabhängigkeit. Fortschr Neurol Psychiatr 50: 279
Schroth G, Mann K (1989) Computertomographie und Kernspintomographie in der klinischen Diagnostik und Erforschung der Alkoholkrankheit. In: Schied HW, Heimann H, Mayer K (Hrsg): Der chronische Alkoholismus. Gustav Fischer, Stuttgart New York: 121–140
Schuckit MA (1985) Genetics and the risk for alcoholism. JAMA 254: 2614–2617
Schuckit MA (1986) Genetic and clinical implications of alcoholism and affective disorders. Am J Psychiatry 143: 140–147
Schuckit MA (1992) Inpatient and residential approaches to the treatment of alcoholism. In: Mendelson JH, Mello NK (eds.) Medical diagnosis and treatment of alcoholism. McGraw-Hill, New York St Louis: 393–419
Schuckit MA (1992) Treatment of Alcoholism in Office and Outpatient Settings. In Mendelson Jh, Mello NK (eds): Medical Diagnosis and Treatment of Alcoholism. New York: McGraw Hill: 363–392
Schuckit MA (1994) Alcohol and depression: a clinical perspective. Acta Psychiatr Scand Suppl 377: 28–32
Schuckit MA (1995) Drug and Alcohol Abuse. A Clinical Guide to Tiagnosis and Treatment, forth edition. New York London: Plenum Medical Book Company
Schuckit MA, Irwin M, Smith TL (1994) One-Year incidence rate of major depression and other psychiatric disorders in 239 alcoholic men. Addiction 89: 441–445
Schuckit MA, Smith TL, Daeppen J-B, Eng M, Hesselbrock VM, Nurnberger JI, Bucholz KK (1998) Clinical Relevance of the Distinction Between Alcohol Dependence With and Without a Physiological Component. Am J Psychiatry 155: 733–740
Schuckit MA, Tipp JE, Bergman M, Reich W, Hesselbrock VM, Smith TL (1997) Comparison of induced and independent major depressive disorders in 2945 alcoholics. Am J Psychiatry 154: 948–957
Schuckit MA, Tipp JE, Bucholz KK, Nurnberger JI, Hesselbrock VM, Crowe RR, Kramer J (1997) The life-time rates of three major mood disorders and four major anxiety disorders in alcoholics and controls. Addiction 92: 1289–1304
Schuckit MA, Winokur G (1971) Alcoholic hallucinosis and schizophrenia: a negative study. Br J Psychiatry 119: 549–550
Schütz H (1992) Spontane interzerebrale Blutungen. Nervenarzt 63: 63–73
Scott DF (1967) Alcoholic hallucinosis: an aetiological study. Br J Addict 62: 113–125
Scott DF, Davies DL, Malherbe MEL (1969) Alcoholic hallucinosis. Int J Addict 4: 319–330
Seitz HK, Lieber CS, Simanowski UA (Hrsg) (1995) Handbuch Alkohol Alkoholismus Alkoholbedingte Organschäden. Leipzig Heidelberg: Johann Ambrosius Barth
Sellers EM, Kalant H (1976) Alcohol intoxication and withdrawal. N Engl J Med 294: 757–762
Sellers EM, Naranjo CA, Harrison M, Devenyi P, Roach C, Sykora K (1983) Diazepam loading: simplified treatment of alcohol withdrawal. Clin Pharmacol Ther 34: 822–826
Selzer ML (1971) The Michigan Alcoholism Screening Test. The quest for a new diagnostic interview. Am J Psychiatry 128: 1653–1658
Senninger N (1997) Indikationen zur Lebertransplantationen. Klinikarzt 8: 195–199.
Shafer D, Jones A (1982) Hepatic encephalopathy and the gamma-aminobutyricacid neurotransmitter system. Lancet I: 18–20
Shandling M, Carlen PL, Lang AE (1990) Parkinsonism in alcohol withdrawal: A follow-up study. Movement Disord 5: 36–39
Shaw GK, Majumdar SK, Waller S, MacGarvie J, Dunn G (1987): Tiapride in the long-term management of alcoholics of anxious or depressive treatment. Br J Psychiatry 150: 164–168
Shaw GK, Waller S, Majumdar SK, Alberts JL, Latham CJ, Dunn G (1994) Tiapride in the prevention of relapse in recently detoxified alcoholics. Br J Psychiatry 165: 515–523
Simon R, Zahn H, Bühringer G, Helas I, Hüllinghorst R, Schmidtobreick B (1997) Jahresstatistik 1996 der ambulanten Beratungs-and Behandlungsstellen für Suchtkranke in der Bundesrepublik Deutschland. Freiburg Hamm Kassel München (EBIS-Berichte Bd. 27)
Siris SG (1990) Pharmacological treatment of substance abusing schizophrenic patients. Schizophrenia Bull 16: 111–122
Skinner HA, Holt S, Sheu WJ, Israel Y (1986) Clinical vs. laboratory detection of alcohol abuse: the alcohol clinical index. Br Med J 292: 1703–1708
Snel HE, Lehmann E, Velikonja M (1983) Piracetam in der Behandlung des alkoholbedingten Delirs. Muench Med Wochenschr 125: 947
Sobczyk P (1983) Diagnosenwechsel im Verlauf von Alkoholdelir und Alkohol-halluzinose. Psychiat Neurol Med Psychol (Leipzig) 35: 618–622
Soni SD, Bamrah JS, Krska J (1991) Effects of alcohol on serum fluphenazine levels in stable chronic schizophranics. Hum Psychopharmacol 84: 272–276
Sonne SC, Brady KT, Morton A (1994) Substance abuse and bipolar affective disorder. J Nerv Ment Dis 182: 349–352
Soyka M (1994) Sucht und Schizophrenie. Nosologische, klinische und therapeutische Fragestellungen. 1. Alkoholismus und Schizophrenie. Fortschr Neurol Psychiat 62: 71–87
Soyka M (1995) Pathophysiologic mechanisms possibly involved in the development of alcohol hallucinosis. Addiction 90: 289–290
Soyka M (1995a) Die Alkoholkrankheit - Diagnostik und Therapie. Weinheim: Chapman & Hall Soyka M (1995b) Psychotherapie und Pharmakotherapie der Alkoholabhängigkeit. Med Welt 47: 273–278
Soyka M (1995c) Psychotherapy and pharmacotherapy for the treatment of alcoholism in Germany. Alcohol Drug Depend 39: 9–13
Soyka M (1995d) Naltrexon in der Behandlung von Abhängigkeitserkrankungen. Psychopharmakotherapie 3: 111–114
Soyka M (1997a) Alkoholismus - eine Krankheit und ihre Therapie. Wissenschaftliche Verlagsgesellschaft
Soyka M (1997b) Ambulante Suchttherapie in Deutschland - rechtliche und gesundheitspolitische Grundlagen und neuere Ergebnisse der Therapieforschung. Recht und Politik im Gesundheitswesen (in Druck)
Soyka M (1997c) Relapse prevention in alcoholism: Recent Advances and Future Possibilities. CNS Drugs 7: 313–327
Soyka M (ed 1996) Acamprosate in Relapse Prevention of Alcoholism. Berlin Heidelberg New York: Springer
Soyka M, Ackenheil M, Sanktjohanser A (1995) Wertigkeit des Carbohydrate-Deficient Transferrin als Alkoholismusmarker: Befunde an stationären Patienten einer speziellen Entgiftungsstation. In: Soyka M (Hrsg): Biologische Alkoholismusmarker. Chapman & Hall:157–166
Soyka M, Albus M, Finelli A, Hofstetter M, Holzbach R, Immler B, Kathmann N, Sand P (1993) Prevalence of alcohol and drug abuse in schizophrenic inpatients. Eur Arch Psychiatry Clin Neurosci 242: 362–372
Soyka M, Baumgartner G, Preuss U, Wachter G, Möller HJ: Katamnestische Untersuchung zur Effizienz einer tagesklinischen Entwöhnungsbehandlung bei Alkoholabhängigkeit. Krankenhauspsychiatrie (in Druck)
Soyka M, Botschev C, Völcker A (1992) Neuroleptic treatment in alcohol hallucinosis - no evidence for increased seizure risk. J Clin Psychopharmacol 12(1): 66–67
Soyka M, De Vry J (1998) Flupenthixol in der Therapie von Suchterkrankungen. In: Glaser T, Soyka M (Hrsg): Flupentixol - Pharmakologie, antipsychotische Wirkung, neue Indikationen. Darmstadt: Steinkopff: 117–130
Soyka M, Hollweg M, Naber D (1996) Alkohol und Depression. Nervenarzt 67: 891–895
Soyka M, Kirchmayer C, Kotter G, John C, Löhnert E, Möller HJ (1997) Neue Möglichkeiten der Therapie und Rehabilitation alkoholabhängiger Patienten - Katamnestische Untersuchung zur Effizienz ambulanter Entwöhnungstherapien am Beispiel einer Modelleinrichtung. Fortschr Neurol Psychiatr 65: 407–412
Soyka M, Lutz W, Kauert G, Schwarz A (1989) Epileptic seizures and alcohol withdrawal: Significance of additional use (and misuse) of drugs and electroencephalographic findings. J Epilepsy 2: 109–113
Soyka M, Naber G, Völcker A (1991) Prevalence of delusional jealousy in different psychiatric disorders - an analysis of 93 cases. Br J Psychiatry 158: 549–553
Soyka M, Niederecker M (1992) Akute Rhabdomyolyse als lebensgefährliche Komplikation eines Delirium tremens. Nervenheilkunde 11: 400–402
Soyka M, Rothenhäußler H-B, Preuss U, Möller HJ (1997) Antidepressiva bei Alkoholabhängigkeit - neue Befunde zu Indikationen, Interaktionen und Effizienz. Psychopharmakotherapie 4: 138–144
Soyka M, Sand P (1995) Successful Treatment with Flupenthixol Decanoate of a Patient with both Schizophrenia and Alcoholism. Pharmacopsychiat 28: 64–65
Soyka M, Sass H, Völcker A (1989) Der alkoholische Eifersuchtswahn - psychopathologische Charakteristika und Versuch der Differenzierung verschiedener Verlaufstypen. Psychiat Praxis 16: 189–193
Soyka M, Wegner U, Möller HJ (1997) Risperidone in Treatment-Reractory Chronic Alcohol Hallucinosis. Pharmacopsychiatry 30: 135–136
Soyka M (1996) Die Alkoholhalluzinose - Pathophysiologie, Klinik und Thera-pie. Nervenarzt 67: 891–895
Soyka M (1996) Dual Diagnosis in Patients with Schizophrenia: Issues in Pharmacological Treatment. CNS Drugs 6: 414–425
Spitzer JB (1981) Auditory Effects of Chronic Alcoholism. Drug Alcohol Depend 8: 317–335
Stapleton JM, Eckardt MJ, Martin P, Adinoff B, Roehrich L, Bone G, Rubinow D, Linnoila M (1988) Treatment of alcoholic organic brain syndrome with the serotonin reuptake inhibitor fluvoxamine: A preliminary study. Adv Alcohol Subst Abuse 7: 47–51
Stapleton JM, Guthrie S, Linnoila M (1986) Effects of alcohol and other psychotropic drugs on eye movements: Relevance to traffic safety. J Stud Alcohol 47: 426–432
Stefan H (1993) Hyper- und Hypovitaminosen. Nervenheilkunde 12: 130–134 Sterns RH, Riggs JE, Schochet SS (1986) Osmotic demyelination syndrome follo-wing correction of hyponatremia. N Engl J Med 314: 1535–1542
Stolberg-Stolberg Graf zu H (1982) Die Behandlung depressiver Syndrome bei chronischem Alkoholismus mit Trazodon. Therapiewoche 32: 1397–1399
Siuppaeck Ch, Barnas C, Falk M, Guenther U, Hummer M, Oberbauer H, Dycha R, Untitworht AB, Fleischhauer UN (1994) Assessment of the Alcohol withdrawal syndrome-validity and reliability of the translated and modified clinical institute withdrawal assessment for alcohol scale (ciwa-a). Addiction 89: 1287–1242
Stuppaeck CH, Whitworth AB, Fleischhacker WW (1993) Abuse potential of carbamazepine. J Nerv Ment Dis 181: 519–520
Sullivan JT, Sykora K, Schneiderman J, Naranjo CA, Sellers EM (1989) Assessment of alcohol withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar). Br J Addict 84: 1353–1357
Surawicz FG (1980) Alcoholic hallucinosis: a missed diagnosis. Can J Psychiatry 25: 57–63
Süß H-M (1995) Zur Wirksamkeit der Therapie bei Alkoholabhängigen: Ergebnisse einer Meta-Analyse. Psychol Rundschau 46: 248–266
Suter PM (1995) Alkohol-Toxizität und Ernährung. In: Seitz HK, Lieber CS, Simanowski UA (Hrsg): Handbuch Alkohol Alkoholismus Alkoholbedingte Organschäden. Leipzig Heidelberg: Johann Ambrosius Barth: 325–348
Swift RM, whelihan W, Kuznetsov O, Buongiorno G, Hsuing H (1994) Naltrexone-induced alterations in human ethanol intoxication. Am J Psychiatry 151: 1463–1467
Tallaksen CME, Bohmer T, Bell H (1992) Blood and serum thiamin and thiamin phosphate esters concentrations in patients with alcohol dependence syndrome before and after thiamin treatment. Alcohol Clin Exp Res 16: 320–325
Tenner SM, Steinberg W (1993) The Admission Serum Lipase: Amylase Ratio Differentiates Alcoholic from Nonalcoholic Acute Pancreatitis. Am J Gastroenterol 87: 1755–1758
Teyssen S, Singer MV (1996) Wirkung vom Alkohol und alkoholischen Getränken auf den Magen und das Pankreas. Klinikarzt 25: 209–215
Thaler H (1977) Voraussetzungen für den alkohololischen Leberschaden. Therapiewoche 27: 6580
Thier P (1993) Alkoholfolgekrankheiten. In: Brandt Th, Dichgans J, Diener HC (Hrsg): Therapie und Verlauf neurologischer Erkrankungen, 2. Aufl. Kohlhammer, Stuttgart Berlin Köln: 841–863
Tiihonen J, Ryynänen O-O, Kauhanen J, Kauhanen J, Hakola HPA, Salaspuro M (1996) Citalopram in the Treatment of Alcoholism: a Double-blind Placebo-controlled Study. Pharmacopsychiat 29: 27–29
Tollefson GD (1989) Serotonin and Alcohol: Interrelationships. Psychopathology 22 (Suppl 1): 37–48
Tollefson GD (1991) Anxiety and alcoholism: a serotonin link. Br J Psychiatry 159 (Suppl 12): 34–49
Tollefson GD, Montague-Clouse J, Tollefson SL (1992) Treatment of comorbid generalized anxiety in a recently detoxified alcoholic population with a selective serotonergic drug (buspirone). J Clin Psychopharmacol 12: 19–26
Tsai G, Gastfriend DR, Coyle JT (1995) The glutamateric basis of human alcoholism. Am J Psychiatry 152: 332–340
Tsai GE, Ragan P, Chang R, Chen S, Linnoila MI, Coyle JT (1998) Increased Glutamatergic Neurotransmission and Oxidative Stress After Alcohol Withdrawal. Am J Psychiatry 155: 726–732
Tsuang JW, Irwin MR, Smith TL, Schuckit MA (1994) Characteristics of men with alcoholic hallucinosis. Addiction 89: 73–78
Ostün B et al. (1997) WHO Study on the reliability and validity of the alcohol and drug use disorder instruments: overview of methods and results. Drug and Alcohol Depend 47: 161–169
Veltrup C (1994) Erfassung des Craving“ bei Alkoholabhängigen mit Hilfe eines neuen Fragebogens (Lübecker Craving-Risiko-Rückfall-Fragebogen): Wien Klin Wschr 106: 75–79
Verner L, Hartmann M, Seitz W (1990) Clonidinsupplementierte Analgosedierung zur postoperativen Delirprophylaxe. Anaesth Intensivther Notfallmed 25: 274–280
Victor M (1992) The effects of alcohol on the nervous system. In: Mendelson JH, Mello NK (Hrsg): Medical diagnosis and treatment of alcoholism. McGraw-Hill, New York, 201–262
Volpicelli JR, Alterman AI, Hayashida M, O’Brien CP (1992) Naltrexone in the treatment of alcohol dependence. Arch Gen Psychiatry 49: 876–880
Volpicelli JR, Watson NT, King AC, Sherman CE, O’Brien CP (1995) Effect of Naltrexone on Alcohol “High” in Alcoholics. Am J Psychiatry 152: 613–615
Wagner HB, Krausz M, Schwoon DR (1996) (Hrsg) Tagesklinik für Suchtkranke. Freiburg: Lambertus Verlag
Walter GF (1978) Marchiafava-Bignami-disease. Arch Psychiat Nervenkr 226: 75
Wanless IR, Medline A, Phillips MJ (1981) Pathology of the hepatic vasculature including hepatic vascular tumors. In Lautt W (ed): Hepatic Circulation in Health and Disease. New York: Raven Press: 257–281
Weltgesundheitsorganisation (1991) Internationale Klassifikation psychischer Störungen ICD-10 Kapitel V (F). Dilling H, Mombour W, Schmidt MH (Hrsg):, Bern Göttingen Toronto: Verlag Hans Huber
Wessel K (1989) Symptomatologie der Alkoholfolgekrankheiten. In: Schied HW, Heimann H, Mayer K (Hrsg) Der chronische Alkoholismus. Gustav Fischer, Stuttgart New York, S 95–102
Westermann H, Wessel T (1996) Die Rolle einer Tagesklinik für Suchtkranke im Rahmen eines regionalen Versorgungsauftrages. In: Wagner HB, Krausz M. Schwoon DR (Hrsg) Tagesklinik für Suchtkranke. Freiburg: Lambertus 58–67
Wetterling T (1994) Delir - Stand der Forschung. Fortschr Neurol Psychiatr 62: 280–289
Wetterling T, Veltrup C (1997): Diagnostik und Therapie von Alkoholproblemen. Berlin Heidelberg New York: Springer
Whitworth AB, Fischer F, Lesch OM, Nimmerrichter A, Oberbauer H, Platz T, Potgieter A, Walter H, Fleischhacker WW (1996) Comparison of acamprosate and placebo in long-term treatment of alcohol dependence. Lancet 347: 1438–1442
WHO (1994) Internationale Klassifikation psychischer Störungen ICD-10 Kapitel V (F) Forschungskriterien. Herausgegeben von H. Dilling, W. Mombour, M.H. Schmidt, E. Schulte-Markwort. Bern: Huber
Wienberg G (1992) Struktur und Dynamik der Suchtkrankenversorgung in der BRD - Ein Versuch die Realität vollständig wahrzunehmen. In: Wienberg G (Hrsg) Die vergessene Mehrheit: zur Realität der Versorgung alkohol- und medikamentenabhängiger Menschen. Bonn: Psychiatrieverlag, 12–60
Wiesbeck G (1998): Flupenthixol in der Rückfallprophylaxe der Alkoholabhängigkeit. Vortrag auf der Wissenschaftstagung der DG-Sucht in Münster 11.-13.03.1998
Wilde MI, Wagstaff AJ (1997) Acamprosate. A Review of its Pharmacology and Clinical Potential in the Management of Alcohol Dependence After Detoxification. Drugs 53: 1038–1053
Wilkins JN (1997) Pharmacotherapy of schizophrenia patients with comorbid substance abuse: Schizophrenia Bull 23: 215–228
Winokur G, Cook B, Liskow B, Fowler R (1993) Alcoholism in manic depressive (bipolar) patients. J Stud Alcohol 54: 574–576
Wise RA, Bozarth MA (1987) A psychomotor stimulant theory of addiction. Psychol Rev 94: 469–492
Wittchen HU (1990) CIDI-Manual: Einführung und Durchführungsbeschreibung. Weinheim: Beltz Test
Wittchen HU, Semler G (1990) CIDI-Composite International Diagnostic Interview. Weinheim: Beltz Test
Woelk H (1995) Folgeerkrankungen des Alkoholabusus: Psychische Veränderungen und Polyneuropathie - Therapie mit Benfotiamin. Vortrag, 5. Hohenheimer Symposion Polyneuropathien und ZNS-Schäden durch Alkoholmißbrauch 6.12.1995
Wrobel N, Thalkofer S, Koeppel C (1991) Clonidintherapie beim Alkoholentzugs-syndrom bei Intensivpatienten. Intensiv Notfallbehandlung 16: 113–116
Zaretsky A, Rector NA, Seeman MV et al. (1993) Current cannabis use and tardive dyskinesia. Schizophrenia Res 11:3–8
Ziegler B, Grub-Seyer S, Huber G (1992) Schlafstörungen bei Alkoholabhängigen. Polysomnographische und computertomographische Untersuchungen. Nervenheilkunde 11: 298–305
Ziegler H (1989): Zur Versorgung Suchtkranker in der BRD. In: Deutsche Hauptstelle gegen die Suchtgefahren (Hrsg). Jahrbuch 90 zur Frage der Suchtgefahren. Hamburg: Neuland, 23–31
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Soyka, M. (1999). Literatur. In: Alkoholabhängigkeit. Optimierte Arzneimitteltherapie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-58462-6_12
Download citation
DOI: https://doi.org/10.1007/978-3-642-58462-6_12
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-65261-8
Online ISBN: 978-3-642-58462-6
eBook Packages: Springer Book Archive